880158-60-1Relevant articles and documents
Arylboronic acids as dual-action FAAH and TRPV1 ligands
Morera, Enrico,Di Marzo, Vincenzo,Monti, Ludovica,Allarà, Marco,Schiano Moriello, Aniello,Nalli, Marianna,Ortar, Giorgio,De Petrocellis, Luciano
, p. 1401 - 1405 (2016)
A series of 31 arylboronic acids designed on the basis of the pharmacophore model for a variety of TRPV1 antagonists was prepared and tested on FAAH and TRPV1 channel. Four of them, that is, compounds 3c, 4a, 5a,b acted as dual FAAH/TRPV1 blockers with IC50 values between 0.56 and 8.11 μM whereas ten others (compounds 1c,f-i, 2c-f, 4b) inhibited FAAH and activated/desensitized TRPV1.
Compounds with medicinal effects due to interaction with the glucocorticoid receptor
-
Page/Page column 15-16, (2010/11/27)
The invention provides for compounds having the structure according to the formula I